Small-Molecule-Directed Endogenous Regeneration of Visual Function in a Mammalian Retinal Degeneration Model
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25031521 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Daphna Mokady und 12 weiteren Autor:innen. Beteiligte Einrichtung: Endogena Therapeutics, Inc., 661 University Ave, Toronto, ON M5G 0B7, Canada. Hauptthemen laut MEDLINE: Retinal Degeneration. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, The Krembil Foundation.
Abstract (Originalsprache)
Degenerative retinal diseases associated with photoreceptor loss are a leading cause of visual impairment worldwide, with limited treatment options. Phenotypic profiling coupled with medicinal chemistry were used to develop a small molecule with proliferative effects on retinal stem/progenitor cells, as assessed in vitro in a neurosphere assay and in vivo by measuring Msx1-positive ciliary body cell proliferation. The compound was identified as having kinase inhibitory activity and was subjected to cellular pathway analysis in non-retinal human primary cell systems. When tested in a disease-relevant murine model of adult retinal degeneration (MNU-induced retinal degeneration), we observed that four repeat intravitreal injections of the compound improved the thickness of the outer nuclear layer along with the regeneration of the visual function, as measured with ERG, visual acuity, and contrast sensitivity tests. This serves as a proof of concept for the use of a small molecule to promote endogenous regeneration in the eye.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Endogena Therapeutics, Inc., 661 University Ave, Toronto, ON M5G 0B7, Canada.
- Department of Molecular Genetics, University of Toronto, Donnelly Centre Rm 1110, 160 College Street, Toronto, ON M5S 3E1, Canada.
- Endogena Therapeutics, AG, Binzmuehlestrasse 170 d, CH-8050 Zuerich, Switzerland.
ORCID-Profile: Brenda L K Coles, Alex Müller, Derek van der Kooy
Förderung
- CIHR
- The Krembil Foundation
Zitieren
APA
Mokady, D., Charish, J., Barretto-Burns, P., Grisé, K. N., Coles, B. L. K., Raab, S., Ortin-Martinez, A., Müller, A., Fasching, B., Jain, P., Drukker, M., van der Kooy, D., & Steger, M. (2024). Small-Molecule-Directed Endogenous Regeneration of Visual Function in a Mammalian Retinal Degeneration Model. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25031521
Vancouver
Mokady D, Charish J, Barretto-Burns P, Grisé KN, Coles BLK, Raab S, et al. Small-Molecule-Directed Endogenous Regeneration of Visual Function in a Mammalian Retinal Degeneration Model. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25031521
BibTeX
@article{Mokady2024,
author = {Mokady, Daphna and Charish, Jason and Barretto-Burns, Patrick and Grisé, Kenneth N and Coles, Brenda L K and Raab, Susanne and Ortin-Martinez, Arturo and Müller, Alex and Fasching, Bernhard and Jain, Payal and Drukker, Micha and van der Kooy, Derek and Steger, Matthias},
title = {Small-Molecule-Directed Endogenous Regeneration of Visual Function in a Mammalian Retinal Degeneration Model},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25031521}
}
EUVIMED